Paul D. Berk

TL;DR: The overall risk of death and other adverse outcomes after bariatric surgery was low and varied considerably according to patient characteristics, andExtreme values of body-mass index were significantly associated with an increased risk of the composite end point, whereas age, sex, race, ethnic group, and other coexisting conditions were not.

TL;DR: In studies to determine the optimal treatment for polycythemia vera, 431 previously untreated patients whose disease met established diagnostic criteria were entered into a prospective, randomized controlled trial between 1967 and 1974; there were no statistically significant differences in survival among the groups, but the increased incidence of leukemia during chlorambucil treatment is statistically significant.

TL;DR: Following bariatric surgery, different weight loss patterns were observed, but most participants maintained much of their weight loss with variable fluctuations over the long term, and most followed trajectories in which weight regain from 3 to 7 years was small relative to year-3 weight loss, but patterns were variable.

TL;DR: Immunofluorescence studies localized the antigen in liver-cell plasma membranes as well as in other major sites of fatty acid transport, compatible with the hypothesis that this protein may act as a receptor in a hepatocellular uptake mechanism for fatty acids.

TL;DR: The goal of the LABS consortium is to accelerate clinical research and understanding of extreme obesity and its complications by evaluating the risks and benefits of bariatric surgery.